Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis.
BACKGROUND
Hodgkin disease and myeloma were recently included in the classification of posttransplant lymphoproliferative disorder (PTLD). However, because their incidence is low, not much is known about their particular features.


METHODS
The incidence, characteristics, risk, and prognostic factors of myeloma, Hodgkin disease, and lymphoid leukemia using the United States Renal Data System from 1991 to 2000 among 66,159 Medicare patients were analyzed.


RESULTS
In all, 1,169 recipients developed a lymphoid disease: 823 (1.2%) non-Hodgkin's lymphomas (NHL), 160 (0.24%) myelomas, 60 (0.1%) Hodgkin lymphomas, and 126 (0.2%) lymphoid leukemias. Older age was associated with an increased risk of myeloma and leukemia. The incidence of hepatitis C virus infection was higher in recipients with myeloma (6.9 vs. 3.9%, P=0.05). Induction therapy was associated with a greater risk of myeloma and leukemia, but not Hodgkin disease. Azathioprine was associated with a lower risk of myeloma, and tacrolimus with a lower risk of Hodgkin disease. According to the type of malignancy, ten-year survival rates were significantly different: 42, 26, 55 and 39% respectively for NHL, myeloma, Hodgkin disease, and leukemia.


CONCLUSIONS
These results support specific features and risk factors related to the occurrence of each type of lymphoid-proliferation and suggest for the first time a possible association between hepatitis C virus and myeloma in kidney transplant recipients.
Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307, USA.
Sophie
S
Caillard
Lawrence Y
LY
Agodoa
Erin M
EM
Bohen
Kevin C
KC
Abbott
D000328:Adult; D000368:Aged; D005260:Female; D006689:Hodgkin Disease / Q000209:etiology* / Q000401:mortality; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D007945:Leukemia, Lymphoid / Q000209:etiology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000209:etiology* / Q000382:microbiology; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate